MoneyWorks4Me

Hikal - Quaterly Results

28 May 2022 Evaluate
A decrease in the sales to Rs. 5023.50 millions was observed for the quarter ended March 2022. The sales stood at Rs. 5324.60 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 207.60 millions from Rs. 509.20 millions, a decline of -59.23% on QoQ basis.Operating Profit reported a sharp decline to 613.10 millions from 1121.30 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 5023.50 5324.60 -5.65 19427.20 17204.40 12.92 19427.20 17204.40 12.92
Other Income 2.70 28.70 -90.59 48.90 49.80 -1.81 48.90 49.80 -1.81
PBIDT 613.10 1121.30 -45.32 3454.50 3278.70 5.36 3454.50 3278.70 5.36
Interest 80.80 99.70 -18.96 312.10 362.00 -13.78 312.10 362.00 -13.78
PBDT 532.30 1021.60 -47.90 3142.40 2916.70 7.74 3142.40 2916.70 7.74
Depreciation 242.30 215.50 12.44 956.70 852.40 12.24 956.70 852.40 12.24
PBT 290.00 806.10 -64.02 2185.70 2064.30 5.88 2185.70 2064.30 5.88
TAX 82.40 296.90 -72.25 580.60 732.80 -20.77 580.60 732.80 -20.77
Deferred Tax 4.40 -45.80 -109.61 -15.90 -62.70 -74.64 -15.90 -62.70 -74.64
PAT 207.60 509.20 -59.23 1605.10 1331.50 20.55 1605.10 1331.50 20.55
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 12.20 21.06 -42.05 17.78 19.06 -6.69 17.78 19.06 -6.69
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..